A dipeptide is a molecule formed by two amino acids linked through a single peptide bond. It is the smallest possible peptide unit, sitting just above the free amino acid in biochemical complexity hierarchy. Despite minimal size, dipeptides play major biological roles and serve as fundamental building blocks in peptide research.
Among the most known natural dipeptides are carnosine (β-alanyl-L-histidine), present in high concentration in skeletal muscle and brain, where it acts as physiological buffer, antioxidant and metal chelator. Anserine (β-alanyl-methylhistidine) is an analog. Aspartame, a globally used synthetic sweetener, is a dipeptide (L-aspartyl-L-phenylalanine methyl ester). Glycyl-glycine, the simplest dipeptide, serves as a laboratory buffer.
Pharmacokinetically, dipeptides display remarkable properties: they are absorbed intact by the intestine via the PepT1 transporter (SLC15A1), a more efficient pathway than free amino acid transport. They also cross certain cellular barriers more readily than longer peptides, making them prime targets for oral bioavailability research.
In research, N-terminal dipeptide motifs are critical because many proteases (notably DPP-4) cleave precisely the first two residues. Understanding and modifying these key dipeptides is the foundation of resistant analog design: semaglutide, liraglutide and modern GLP-1 agonists owe their plasma stability to targeted modifications of the N-terminal dipeptide.
Dipeptides rarely appear as finished products in a research peptide catalog, but they constantly surface as synthesis intermediates, as proteolytic degradation products to identify by LC-MS, and as essential design motifs for optimizing stability, affinity and selectivity.